Log In
Print
BCIQ
Print
Print this Print this
 

BAX 855

Also known as: BAX-855

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionPegylated form of recombinant Factor VIII
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II/III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation

Partner

Nektar Therapeutics


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today